Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile.

Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase. Molecu-

& Lymphoma. Colorimetric assessment of BCR-ABL1 transcripts in clinical samples via gold nanoprobes. Analytical and Bioanalytical Chemistry. • Veigas B, Pinto J,

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.. O'Brien SG, Guilhot F,

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA

leucemia mielóide aguda em primeira remissão completa: análise de 62 pacientes Allogeneic and autologous hematopoietic stem cell transplantation in acute myeloid leukemia in

Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase – the importance of a major molecular response1. Medical

PFS: progression-free survival; OS: overall survival; AML: acute myeloid leukemia; ALL: acute lymphoblastic leukemia; CR: complete remission; RR: response rate; CMML:

Simultaneous occurrence of chronic myeloid leukemia and chronic lymphocytic leukemia: report of an unusual case. Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A,